Thermo Fisher Scientific Inc (TMO)
557.87
-7.36
(-1.30%)
USD |
NYSE |
Apr 15, 16:00
557.86
-0.01
(-0.00%)
After-Hours: 20:00
Thermo Fisher Scientific Revenue (TTM): 42.86B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 42.86B |
| September 30, 2023 | 43.42B |
| June 30, 2023 | 43.52B |
| March 31, 2023 | 43.81B |
| December 31, 2022 | 44.92B |
| September 30, 2022 | 44.17B |
| June 30, 2022 | 42.82B |
| March 31, 2022 | 41.12B |
| December 31, 2021 | 39.21B |
| September 30, 2021 | 39.06B |
| June 30, 2021 | 38.25B |
| March 31, 2021 | 35.89B |
| December 31, 2020 | 32.22B |
| September 30, 2020 | 28.50B |
| June 30, 2020 | 26.25B |
| March 31, 2020 | 25.65B |
| December 31, 2019 | 25.54B |
| September 30, 2019 | 25.22B |
| June 30, 2019 | 24.87B |
| March 31, 2019 | 24.63B |
| December 31, 2018 | 24.36B |
| September 30, 2018 | 23.90B |
| June 30, 2018 | 23.09B |
| March 31, 2018 | 22.01B |
| December 31, 2017 | 20.92B |
| Date | Value |
|---|---|
| September 30, 2017 | 19.82B |
| June 30, 2017 | 19.20B |
| March 31, 2017 | 18.74B |
| December 31, 2016 | 18.27B |
| September 30, 2016 | 17.97B |
| June 30, 2016 | 17.61B |
| March 31, 2016 | 17.34B |
| December 31, 2015 | 16.96B |
| September 30, 2015 | 16.81B |
| June 30, 2015 | 16.85B |
| March 31, 2015 | 16.90B |
| December 31, 2014 | 16.89B |
| September 30, 2014 | 15.86B |
| June 30, 2014 | 14.88B |
| March 31, 2014 | 13.80B |
| December 31, 2013 | 13.09B |
| September 30, 2013 | 12.88B |
| June 30, 2013 | 12.78B |
| March 31, 2013 | 12.64B |
| December 31, 2012 | 12.51B |
| September 30, 2012 | 12.34B |
| June 30, 2012 | 12.19B |
| March 31, 2012 | 11.93B |
| December 31, 2011 | 11.60B |
| September 30, 2011 | 11.05B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
24.87B
Minimum
Jun 2019
44.92B
Maximum
Dec 2022
36.17B
Average
39.06B
Median
Sep 2021
Revenue (TTM) Benchmarks
| Fonar Corp | 102.42M |
| XWELL Inc | 30.26M |
| ProPhase Labs Inc | 44.38M |
| Applied DNA Sciences Inc | 8.996M |
| Veracyte Inc | 361.05M |